SMS PHARMACEUTICALS LTD. (SMSPHARMA)

NSE: ₹353.65
BSE: ₹353.80
Stock Performance
Corporate Announcements
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.

Please find the annexure

2026-06-05 15:42:08
Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcripts of the Conference call held on 27th May, 2026

2026-05-30 14:05:22
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and year ended 31st March, 2026

2026-05-27 17:03:18
Announcement under Regulation 30 (LODR)-Newspaper Publication

copy of newspaper publication

2026-05-25 14:59:51
Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation

2026-05-23 18:12:57
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on Financial Results for the year ended 31.03.2026

2026-05-23 17:49:06
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Investor Call

2026-05-22 16:57:15
Announcement under Regulation 30 (LODR)-Change in Registered Office Address

Please find the enclosure

2026-05-22 15:24:16
Statement Of Deviation & Variation For The Quarter Ended 31St March, 2026

Please find the enclosure

2026-05-22 15:19:24
Announcement under Regulation 30 (LODR)-Change in Management

Re-appointment of Auditors of the Company

2026-05-22 15:15:18

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 135.34 166.64 161.48 245.80 164.45 196.75 173.35 248.20 196.05 242.43 210.45 237.95
YOY Revenue Growth % 110.19% 4.52% 8.52% 64.5% 21.51% 18.07% 7.35% 0.98% 19.21% 23.22% 21.4% -4.13%
Other Income 0.51 0.81 1.49 1.65 1.37 1.30 2.13 1.42 0.59 1.43 3.75 2.57
Total Income 135.85 167.45 162.97 247.44 165.82 198.05 175.48 249.62 196.64 243.86 214.20 240.52
Total Expenses + 123.17 152.29 146.45 225.71 143.99 178.51 153.04 221.09 172.27 209.82 183.04 213.46
Cost of Materials Consumed 91.72 103.59 132.48 97.47 107.24 158.77 118.32 117.54 146.66 106.56 139.19 128.46
Employee Benefit Expense 13.55 13.65 14.02 20.12 16.88 17.93 18.64 26.63 18.18 19.25 21.05 29.47
Other Expenses 21.10 27.36 27.21 31.36 26.09 31.66 36.01 32.85 27.52 34.99 31.98 35.36
Operating Profit 12.17 14.35 15.04 20.09 20.46 18.24 20.31 27.10 23.78 32.61 27.41 24.49
OPM % 9% 8.6% 9.3% 8.2% 12.4% 9.3% 11.7% 10.9% 12.1% 13.5% 13% 10.3%
Profit Before Tax + 12.68 15.16 16.53 21.74 21.83 19.54 22.44 28.52 24.37 34.04 31.16 27.07
Tax Expense 3.34 3.43 5.05 4.46 5.35 5.44 4.20 8.21 3.88 8.73 7.69 -5.65
Tax % 26.3% 22.7% 30.5% 20.5% 24.5% 27.9% 18.7% 28.8% 15.9% 25.6% 24.7% -20.9%
Profit After Tax 9.34 11.73 11.48 17.28 16.48 14.10 18.24 20.31 20.49 25.31 23.47 32.71
EPS (Basic) 1.10 1.39 1.36 2.04 1.95 1.69 2.15 2.40 2.31 2.84 2.59 3.58

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 886.87 782.75 709.26 522.05 519.87 563.18 411.95
YOY Revenue Growth % 13.3% 10.36% 35.86% 0.42% -7.69% 36.71% -
Other Income 8.35 6.22 4.46 4.89 5.20 3.45 5.11
Total Income 895.22 788.97 713.72 526.94 525.07 566.63 417.06
Total Expenses + 778.59 696.64 647.62 521.59 456.57 415.33 366.30
Cost of Materials Consumed 516.44 501.87 425.26 299.73 387.95 313.27 259.50
Employee Benefit Expense 87.96 80.08 64.15 55.04 51.02 41.17 39.35
Other Expenses 134.29 126.61 104.23 76.69 79.07 60.90 46.31
Operating Profit 108.28 86.11 61.65 0.46 63.30 147.84 45.64
OPM % 12.2% 11% 8.7% 0.1% 12.2% 26.3% 11.1%
Profit Before Exceptional 116.64 92.34 66.11 5.35 68.50 91.12 50.76
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 116.64 92.34 66.11 5.35 68.50 91.12 50.76
Tax Expense 14.65 23.20 16.28 12.41 6.28 28.59 18.07
Tax % 12.6% 25.1% 24.6% 232% 9.2% 31.4% 35.6%
Profit After Tax 101.99 69.14 49.83 -7.06 62.22 62.53 32.69
EPS (Basic) 11.15 8.16 5.89 -0.83 7.35 7.39 3.73

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 724.43 598.21 500.20 468.96 482.45 0.00 389.13
Property, Plant & Equipment 531.22 530.85 434.19 409.50 434.07 0.00 275.19
Capital Work in Progress 121.64 34.67 30.27 33.19 11.00 0.00 42.12
Non-Current Investments 26.28 11.68 10.94 10.52 21.53 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.83
Other Intangible Assets 2.80 2.13 2.66 1.47 2.55 0.00 66.53
Current Assets + 638.01 554.47 533.89 410.65 377.05 0.00 218.78
Inventories 351.21 284.73 233.70 223.50 251.10 0.00 129.20
Trade Receivables 215.87 203.23 236.23 148.35 48.52 0.00 48.77
Cash and Cash Equivalents 45.88 41.40 36.04 7.38 46.58 0.00 9.54
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 785.81 639.64 536.33 460.53 470.29 0.00 348.24
Equity Share Capital 9.37 8.87 8.47 8.47 8.47 0.00 8.47
Other Equity 776.44 630.78 527.86 452.06 461.82 0.00 339.77
Non-Current Liabilities 223.65 188.67 166.05 164.17 192.93 0.00 114.47
Current Liabilities 352.98 324.37 331.72 254.91 196.29 0.00 145.21
Total Liabilities 576.63 513.04 497.76 419.08 389.21 0.00 259.68

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 59.22 81.71 50.12 22.45 40.23 0.00 0.00
Cash from Investing Activities -130.78 -123.43 -52.07 -29.69 -27.15 0.00 0.00
Cash from Financing Activities 76.03 47.08 30.68 -31.97 -6.92 0.00 0.00
Net Increase/Decrease in Cash 4.48 5.36 28.73 -39.21 6.16 0.00 0.00